MOLECULAR UPGRADE
INDUSTRIAL RELEASE

Bioactive compounds programmed for real industrial, ready-to-use conditions.

Bulk ingredients

Functional compounds & ready-to-use premixes.

See Products

R&D platform

Bioactive & targeted delivery systems.

Open Platform

ASPEGON

1x Higher bioavailability
1x Targeted brain delivery
1x Prolonged release

PLATFORM

Laboratory research — low bioavailability challenge

Problem

Hundreds of verified small molecules remain untapped due to low bioavailability.

Molecule suspended in liquid — Aspegon solution

Our Solution

We modify their structures into effective, commercially scalable complexes.

HYBRID MODEL

Flexible CRO R&D.
100% IP retention.

In-house scale-up.
Own manufacturing facilities.

B2B TRANSFER

100% Data Validation

Performed exclusively at certified centers.

Certified laboratory data validation

1:1 Purpose Funding

Targeted financing via the Stage-Gate system.

Targeted financing via Stage-Gate system

360° Full Cycle

B2B transfer from raw materials to ready-to-use premises.

B2B transfer from raw materials to ready-to-use premises


PRODUCTION INFRASTRUCTURE

End-to-End

From raw material preparation to bulk substance release.

60% Reserve

Engineering potential for rapid volume scale-up.

Dual Function

Small-scale aerosol production and industrial testing center.

Aspegon production facility interior

Let's build the next generation of functional ingredients.